Jing Huang

11PUBLICATIONS
27CO-AUTHORS
Molecular targetsCancer cell biologyCancer diagnosisElectrochemical energy storage and conversionMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 01, 2026
Epigenetic Repression of Type I Interferon Signaling by RUNX2 Drives Immune Checkpoint Blockade Resistance in Osteosarcoma.

|Jul 27, 2026
Cancer stem cells are hyper-responsive sensors of the tumour microenvironment and regulate metastasis dynamics through YAP/TAZ.

|Jul 31, 2025
Transient APC/C inactivation by mTOR boosts glycolysis during cell cycle entry.

Debasish Paul, Derek L Bolhuis, Hualong Yan

|Jun 26, 2025
Hyper-responsiveness of cancer stem cells to microenvironmental cues controls metastasis and therapy response through YAP/TAZ/TEAD.

Binwu Tang, Jacob Minin, Victoria Gonzalez

|Jul 25, 2023
SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma.

Young-Im Kim, Yu-Chou Tseng, Gamze Ayaz

|Apr 28, 2023
Autophagy Inhibition as a Potential Therapeutic Strategy for Breast Cancer with Mitochondrial Translation Defect Caused by CBFB-Deficiency.

Navdeep Malik, Hualong Yan, Young-Im Kim

Pageof 2

Frequent Collaborators

4 joint publications

Howard Yang

4 joint publications

Hualong Yan

3 joint publications

Andy D Tran

3 joint publications

Michael Kruhlak